{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:32:36Z","timestamp":1793935956171,"version":"4.8.0"},"reference-count":364,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41573-024-01105-0","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:30:50Z","timestamp":1736839850000},"page":"276-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":177,"title":["Targeting mitophagy in neurodegenerative diseases"],"prefix":"10.1038","volume":"24","author":[{"given":"Odetta","family":"Antico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Hertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miratul M. K.","family":"Muqit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0818-0446","authenticated-orcid":false,"given":"Laura E.","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"1105_CR1","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen, M. G., Kim, M.-O. & Geschwind, M. D. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 10, a033118 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1105_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nature09486","volume":"467","author":"N Lane","year":"2010","unstructured":"Lane, N. & Martin, W. The energetics of genome complexity. Nature 467, 929\u2013934 (2010).","journal-title":"Nature"},{"key":"1105_CR3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","volume":"283","author":"DC Wallace","year":"1999","unstructured":"Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482\u20131488 (1999).","journal-title":"Science"},{"key":"1105_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tcb.2014.11.002","volume":"25","author":"M Scheibye-Knudsen","year":"2015","unstructured":"Scheibye-Knudsen, M. et al. Protecting the mitochondrial powerhouse. Trends Cell Biol. 25, 158\u2013170 (2015).","journal-title":"Trends Cell Biol."},{"key":"1105_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.neuron.2017.09.055","volume":"96","author":"T Misgeld","year":"2017","unstructured":"Misgeld, T. & Schwarz, T. L. Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture. Neuron 96, 651\u2013666 (2017).","journal-title":"Neuron"},{"key":"1105_CR6","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner, N. et al. Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31, 3038\u20133062 (2012).","journal-title":"EMBO J."},{"key":"1105_CR7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.neuron.2022.03.015","volume":"110","author":"XT Cheng","year":"2022","unstructured":"Cheng, X. T., Huang, N. & Sheng, Z. H. Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration. Neuron 110, 1899\u20131923 (2022).","journal-title":"Neuron"},{"key":"1105_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrm.2017.110","volume":"19","author":"T Shpilka","year":"2018","unstructured":"Shpilka, T. & Haynes, C. M. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat. Rev. Mol. Cell Biol. 19, 109\u2013120 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1105_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"1105_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","volume":"11","author":"F Burte","year":"2015","unstructured":"Burte, F. et al. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11\u201324 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"1105_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson, D. M. et al. Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714 (2023).","journal-title":"Cell"},{"key":"1105_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich, M. T. et al. Mitochondrial dysfunction in Parkinson\u2019s disease\u2014a key disease hallmark with therapeutic potential. Mol. Neurodegen. 18, 83 (2023).","journal-title":"Mol. Neurodegen."},{"key":"1105_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi, A. et al. Emerging therapies in Parkinson disease\u2014repurposed drugs and new approaches. Nat. Rev. Neurol. 15, 204\u2013223 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"1105_CR14","doi-asserted-by":"publisher","first-page":"615461","DOI":"10.3389\/fcell.2020.615461","volume":"8","author":"J Prasuhn","year":"2020","unstructured":"Prasuhn, J., Davis, R. L. & Kumar, K. R. Targeting mitochondrial impairment in Parkinson\u2019s disease: challenges and opportunities. Front. Cell Dev. Biol. 8, 615461 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1105_CR15","doi-asserted-by":"publisher","first-page":"103244","DOI":"10.1016\/j.ebiom.2021.103244","volume":"65","author":"A Singh","year":"2021","unstructured":"Singh, A., Faccenda, D. & Campanella, M. Pharmacological advances in mitochondrial therapy. eBioMedicine 65, 103244 (2021).","journal-title":"eBioMedicine"},{"key":"1105_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03596-1","volume":"24","author":"JE Svensson","year":"2024","unstructured":"Svensson, J. E. et al. Evaluating the effect of rapamycin treatment in Alzheimer\u2019s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol. BMC Neurol. 24, 111 (2024).","journal-title":"BMC Neurol."},{"key":"1105_CR17","doi-asserted-by":"publisher","first-page":"114889","DOI":"10.1016\/j.bbr.2024.114889","volume":"463","author":"W Zheng","year":"2024","unstructured":"Zheng, W. et al. Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5\u00d7FAD mice. Behav. Brain Res. 463, 114889 (2024).","journal-title":"Behav. Brain Res."},{"key":"1105_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup, S. et al. NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 30, 630\u2013655 (2019).","journal-title":"Cell Metab."},{"key":"1105_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43514-6","volume":"14","author":"H Berven","year":"2023","unstructured":"Berven, H. et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson\u2019s disease. Nat. Commun. 14, 7793 (2023).","journal-title":"Nat. Commun."},{"key":"1105_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra, D. et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795\u2013803 (2008).","journal-title":"J. Cell Biol."},{"key":"1105_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda, N. et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211\u2013221 (2010).","journal-title":"J. Cell Biol."},{"key":"1105_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2016","volume":"3","author":"K Okatsu","year":"2012","unstructured":"Okatsu, K. et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat. Commun. 3, 1016 (2012).","journal-title":"Nat. Commun."},{"key":"1105_CR23","doi-asserted-by":"publisher","first-page":"36372","DOI":"10.1074\/jbc.M113.509653","volume":"288","author":"K Okatsu","year":"2013","unstructured":"Okatsu, K. et al. A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment. J. Biol. Chem. 288, 36372\u201336384 (2013).","journal-title":"J. Biol. Chem."},{"key":"1105_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. & Youle, R. J. The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85, 257\u2013273 (2015).","journal-title":"Neuron"},{"key":"1105_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309\u2013314 (2015).","journal-title":"Nature"},{"key":"1105_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","volume":"60","author":"JM Heo","year":"2015","unstructured":"Heo, J. M. et al. The PINK1\u2013PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7\u201320 (2015).","journal-title":"Mol. Cell"},{"key":"1105_CR27","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.4161\/auto.24633","volume":"9","author":"K Yamano","year":"2013","unstructured":"Yamano, K. & Youle, R. J. PINK1 is degraded through the N-end rule pathway. Autophagy 9, 1758\u20131769 (2013).","journal-title":"Autophagy"},{"key":"1105_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.celrep.2017.06.022","volume":"20","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The ubiquitination of PINK1 is restricted to its mature 52-kDa form. Cell Rep. 20, 30\u201339 (2017).","journal-title":"Cell Rep."},{"key":"1105_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-018-0224-x","volume":"559","author":"C Gladkova","year":"2018","unstructured":"Gladkova, C. et al. Mechanism of Parkin activation by PINK1. Nature 559, 410\u2013414 (2018).","journal-title":"Nature"},{"key":"1105_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/embor.2013.168","volume":"14","author":"GF Allen","year":"2013","unstructured":"Allen, G. F., Toth, R., James, J. & Ganley, I. G. Loss of iron triggers PINK1\/parkin-independent mitophagy. EMBO Rep. 14, 1127\u20131135 (2013).","journal-title":"EMBO Rep."},{"key":"1105_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32564-x","volume":"13","author":"JB Michaelis","year":"2022","unstructured":"Michaelis, J. B. et al. Protein import motor complex reacts to mitochondrial misfolding by reducing protein import and activating mitophagy. Nat. Commun. 13, 5164 (2022).","journal-title":"Nat. Commun."},{"key":"1105_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.devcel.2011.12.014","volume":"22","author":"M Lazarou","year":"2012","unstructured":"Lazarou, M. et al. Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase parkin. Dev. Cell 22, 320\u2013333 (2012).","journal-title":"Dev. Cell"},{"key":"1105_CR33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1083\/jcb.201008084","volume":"191","author":"SM Jin","year":"2010","unstructured":"Jin, S. M. et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933\u2013942 (2010).","journal-title":"J. Cell Biol."},{"key":"1105_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41586-021-04340-2","volume":"602","author":"ZY Gan","year":"2022","unstructured":"Gan, Z. Y. et al. Activation mechanism of PINK1. Nature 602, 328\u2013335 (2022).","journal-title":"Nature"},{"key":"1105_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molcel.2021.11.012","volume":"82","author":"S Rasool","year":"2022","unstructured":"Rasool, S. et al. Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex. Mol. Cell 82, 44\u201359.e6 (2022).","journal-title":"Mol. Cell"},{"key":"1105_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.201402104","volume":"205","author":"LA Kane","year":"2014","unstructured":"Kane, L. A. et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143\u2013153 (2014).","journal-title":"J. Cell Biol."},{"key":"1105_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nature13392","volume":"510","author":"F Koyano","year":"2014","unstructured":"Koyano, F. et al. Ubiquitin is phosphorylated by PINK1 to activate Parkin. Nature 510, 162\u2013166 (2014).","journal-title":"Nature"},{"key":"1105_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1042\/BJ20140334","volume":"460","author":"A Kazlauskaite","year":"2014","unstructured":"Kazlauskaite, A. et al. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem. J. 460, 127\u2013139 (2014).","journal-title":"Biochem. J."},{"key":"1105_CR39","doi-asserted-by":"publisher","first-page":"120080","DOI":"10.1098\/rsob.120080","volume":"2","author":"C Kondapalli","year":"2012","unstructured":"Kondapalli, C. et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating serine 65. Open. Biol. 2, 120080 (2012).","journal-title":"Open. Biol."},{"key":"1105_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature14879","volume":"524","author":"T Wauer","year":"2015","unstructured":"Wauer, T. et al. Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature 524, 370\u2013374 (2015).","journal-title":"Nature"},{"key":"1105_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature12043","volume":"496","author":"SA Sarraf","year":"2013","unstructured":"Sarraf, S. A. et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496, 372\u2013376 (2013).","journal-title":"Nature"},{"key":"1105_CR42","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.molcel.2019.11.013","volume":"77","author":"A Ordureau","year":"2020","unstructured":"Ordureau, A. et al. Global landscape and dynamics of Parkin and USP30-dependent ubiquitylomes in iNeurons during mitophagic signaling. Mol. Cell 77, 1124\u20131142 (2020).","journal-title":"Mol. Cell"},{"key":"1105_CR43","doi-asserted-by":"publisher","first-page":"eabj0722","DOI":"10.1126\/sciadv.abj0722","volume":"7","author":"O Antico","year":"2021","unstructured":"Antico, O. et al. Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1. Sci. Adv. 7, eabj0722 (2021).","journal-title":"Sci. Adv."},{"key":"1105_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler, S. et al. PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat. Cell Biol. 12, 119\u2013131 (2010).","journal-title":"Nat. Cell Biol."},{"key":"1105_CR45","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","volume":"20","author":"NC Chan","year":"2011","unstructured":"Chan, N. C. et al. Broad activation of the ubiquitin\u2013proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 20, 1726\u20131737 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR46","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4161\/auto.6.8.13426","volume":"6","author":"D Narendra","year":"2010","unstructured":"Narendra, D. et al. p62\/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6, 1090\u20131106 (2010).","journal-title":"Autophagy"},{"key":"1105_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.molcel.2014.09.007","volume":"56","author":"A Ordureau","year":"2014","unstructured":"Ordureau, A. et al. Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol. Cell 56, 360\u2013375 (2014).","journal-title":"Mol. Cell"},{"key":"1105_CR48","doi-asserted-by":"publisher","first-page":"E4439","DOI":"10.1073\/pnas.1405752111","volume":"111","author":"YC Wong","year":"2014","unstructured":"Wong, Y. C. & Holzbaur, E. L. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl Acad. Sci. USA 111, E4439\u2013E4448 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1080\/15548627.2015.1009792","volume":"11","author":"YC Wong","year":"2015","unstructured":"Wong, Y. C. & Holzbaur, E. L. Temporal dynamics of PARK2\/Parkin and OPTN\/optineurin recruitment during the mitophagy of damaged mitochondria. Autophagy 11, 422\u2013424 (2015).","journal-title":"Autophagy"},{"key":"1105_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrm.2017.129","volume":"19","author":"JW Harper","year":"2018","unstructured":"Harper, J. W., Ordureau, A. & Heo, J. M. Building and decoding ubiquitin chains for mitophagy. Nat. Rev. Mol. Cell Biol. 19, 93\u2013108 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1105_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","journal-title":"Cell Res."},{"key":"1105_CR52","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","volume":"510","author":"B Bingol","year":"2014","unstructured":"Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes Parkin-mediated mitophagy. Nature 510, 370\u2013375 (2014).","journal-title":"Nature"},{"key":"1105_CR53","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000768","volume":"3","author":"EV Rusilowicz-Jones","year":"2020","unstructured":"Rusilowicz-Jones, E. V. et al. USP30 sets a trigger threshold for PINK1\u2013PARKIN amplification of mitochondrial ubiquitylation. Life Sci. Alliance 3, e202000768 (2020).","journal-title":"Life Sci. Alliance"},{"key":"1105_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb3097","volume":"17","author":"CN Cunningham","year":"2015","unstructured":"Cunningham, C. N. et al. USP30 and Parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Nat. Cell Biol. 17, 160\u2013169 (2015).","journal-title":"Nat. Cell Biol."},{"key":"1105_CR55","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41556-021-00798-4","volume":"23","author":"T Konig","year":"2021","unstructured":"Konig, T. et al. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. Nat. Cell Biol. 23, 1271\u20131286 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1105_CR56","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nsmb.3475","volume":"24","author":"M Gersch","year":"2017","unstructured":"Gersch, M. et al. Mechanism and regulation of the Lys6-selective deubiquitinase USP30. Nat. Struct. Mol. Biol. 24, 920\u2013930 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1105_CR57","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.molcel.2023.08.021","volume":"83","author":"L Uoselis","year":"2023","unstructured":"Uoselis, L., Nguyen, T. N. & Lazarou, M. Mitochondrial degradation: mitophagy and beyond. Mol. Cell 83, 3404\u20133420 (2023).","journal-title":"Mol. Cell"},{"key":"1105_CR58","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1084\/jem.186.12.1975","volume":"186","author":"G Chen","year":"1997","unstructured":"Chen, G. et al. The E1B 19K\/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186, 1975\u20131983 (1997).","journal-title":"J. Exp. Med."},{"key":"1105_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/embor.2009.256","volume":"11","author":"I Novak","year":"2010","unstructured":"Novak, I. et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 11, 45\u201351 (2010).","journal-title":"EMBO Rep."},{"key":"1105_CR60","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/15548627.2016.1151580","volume":"12","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy 12, 689\u2013702 (2016).","journal-title":"Autophagy"},{"key":"1105_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8527","volume":"6","author":"T Murakawa","year":"2015","unstructured":"Murakawa, T. et al. Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nat. Commun. 6, 7527 (2015).","journal-title":"Nat. Commun."},{"key":"1105_CR62","doi-asserted-by":"publisher","first-page":"947","DOI":"10.15252\/embr.201643147","volume":"18","author":"Z Bhujabal","year":"2017","unstructured":"Bhujabal, Z. et al. FKBP8 recruits LC3A to mediate parkin-independent mitophagy. EMBO Rep. 18, 947\u2013961 (2017).","journal-title":"EMBO Rep."},{"key":"1105_CR63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cell.2016.11.042","volume":"168","author":"Y Wei","year":"2017","unstructured":"Wei, Y. et al. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell 168, 224\u2013238 (2017).","journal-title":"Cell"},{"key":"1105_CR64","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/j.molcel.2022.06.004","volume":"82","author":"SA Killackey","year":"2022","unstructured":"Killackey, S. A. et al. Mitochondrial protein import stress regulates the LC3 lipidation step of mitophagy through NLRX1 and RRBP1. Mol. Cell 82, 2815\u20132831 (2022).","journal-title":"Mol. Cell"},{"key":"1105_CR65","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41418-019-0404-8","volume":"27","author":"F Strappazzon","year":"2020","unstructured":"Strappazzon, F. et al. HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy. Cell Death Diff. 27, 1155\u20131168 (2020).","journal-title":"Cell Death Diff."},{"key":"1105_CR66","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1080\/15548627.2022.2062111","volume":"18","author":"MN Iriondo","year":"2022","unstructured":"Iriondo, M. N. et al. LC3 subfamily in cardiolipin-mediated mitophagy: a comparison of the LC3A, LC3B and LC3C homologs. Autophagy 18, 2985\u20133003 (2022).","journal-title":"Autophagy"},{"key":"1105_CR67","doi-asserted-by":"publisher","unstructured":"Lam, W. K. et al. Presynapses are mitophagy pit stops that prevent axon degeneration. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.09.611943 (2024).","DOI":"10.1101\/2024.09.09.611943"},{"key":"1105_CR68","doi-asserted-by":"publisher","unstructured":"Adriaenssens, E. et al. Reconstitution of BNIP3\/NIX-mediated autophagy reveals two pathways and hierarchical flexibility of the initiation machinery. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.08.28.609967 (2024).","DOI":"10.1101\/2024.08.28.609967"},{"key":"1105_CR69","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.15252\/embj.201488104","volume":"33","author":"A Sugiura","year":"2014","unstructured":"Sugiura, A. et al. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 33, 2142\u20132156 (2014).","journal-title":"EMBO J."},{"key":"1105_CR70","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.cub.2010.05.066","volume":"20","author":"E Braschi","year":"2010","unstructured":"Braschi, E. et al. Vps35 mediates vesicle transport between the mitochondria and peroxisomes. Curr. Biol. 20, 1310\u20131315 (2010).","journal-title":"Curr. Biol."},{"key":"1105_CR71","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41419-020-03228-9","volume":"11","author":"CC Chiu","year":"2020","unstructured":"Chiu, C. C. et al. (D620N) VPS35 causes the impairment of Wnt\/\u03b2-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death Dis. 11, 1018 (2020).","journal-title":"Cell Death Dis."},{"key":"1105_CR72","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.28365","volume":"36","author":"Z Hanss","year":"2021","unstructured":"Hanss, Z. et al. Mitochondrial and clearance impairment in p.D620N VPS35 patient-derived neurons. Mov. Disord. 36, 704\u2013715 (2021).","journal-title":"Mov. Disord."},{"key":"1105_CR73","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/cr.2016.104","volume":"26","author":"RF Roberts","year":"2016","unstructured":"Roberts, R. F. & Fon, E. A. Presenting mitochondrial antigens: PINK1, Parkin and MDVs steal the show. Cell Res. 26, 1180\u20131181 (2016).","journal-title":"Cell Res."},{"key":"1105_CR74","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud, D. et al. Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell 166, 314\u2013327 (2016).","journal-title":"Cell"},{"key":"1105_CR75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1083\/jcb.201603105","volume":"214","author":"GL McLelland","year":"2016","unstructured":"McLelland, G. L. et al. Syntaxin-17 delivers PINK1\/Parkin-dependent mitochondrial vesicles to the endolysosomal system. J. Cell Biol. 214, 275\u2013291 (2016).","journal-title":"J. Cell Biol."},{"key":"1105_CR76","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.neuron.2013.10.035","volume":"80","author":"G Fishell","year":"2013","unstructured":"Fishell, G. & Heintz, N. The neuron identity problem: form meets function. Neuron 80, 602\u2013612 (2013).","journal-title":"Neuron"},{"key":"1105_CR77","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.celrep.2013.06.040","volume":"4","author":"T Sun","year":"2013","unstructured":"Sun, T. et al. Motile axonal mitochondria contribute to the variability of presynaptic strength. Cell Rep. 4, 413\u2013419 (2013).","journal-title":"Cell Rep."},{"key":"1105_CR78","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","volume":"75","author":"JJ Harris","year":"2012","unstructured":"Harris, J. J., Jolivet, R. & Attwell, D. Synaptic energy use and supply. Neuron 75, 762\u2013777 (2012).","journal-title":"Neuron"},{"key":"1105_CR79","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1038\/s44318-024-00241-y","volume":"43","author":"A Rappe","year":"2024","unstructured":"Rappe, A. et al. Longitudinal autophagy profiling of the mammalian brain reveals sustained mitophagy throughout healthy aging. EMBO J. 43, 6199\u20136231 (2024).","journal-title":"EMBO J."},{"key":"1105_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50260","volume":"9","author":"CS Evans","year":"2020","unstructured":"Evans, C. S. & Holzbaur, E. L. Degradation of engulfed mitochondria is rate-limiting in optineurin-mediated mitophagy in neurons. eLife 9, e50260 (2020).","journal-title":"eLife"},{"key":"1105_CR81","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/15548627.2020.1734330","volume":"16","author":"CS Evans","year":"2020","unstructured":"Evans, C. S. & Holzbaur, E. L. F. Lysosomal degradation of depolarized mitochondria is rate-limiting in OPTN-dependent neuronal mitophagy. Autophagy 16, 962\u2013964 (2020).","journal-title":"Autophagy"},{"key":"1105_CR82","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jmb.2019.06.031","volume":"432","author":"CS Evans","year":"2020","unstructured":"Evans, C. S. & Holzbaur, E. L. F. Quality control in neurons: mitophagy and other selective autophagy mechanisms. J. Mol. Biol. 432, 240\u2013260 (2020).","journal-title":"J. Mol. Biol."},{"key":"1105_CR83","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1523\/JNEUROSCI.4401-15.2016","volume":"36","author":"S Maday","year":"2016","unstructured":"Maday, S. & Holzbaur, E. L. Compartment-specific regulation of autophagy in primary neurons. J. Neurosci. 36, 5933\u20135945 (2016).","journal-title":"J. Neurosci."},{"key":"1105_CR84","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4161\/auto.20218","volume":"8","author":"Q Cai","year":"2012","unstructured":"Cai, Q., Zakaria, H. M. & Sheng, Z. H. Long time-lapse imaging reveals unique features of PARK2\/parkin-mediated mitophagy in mature cortical neurons. Autophagy 8, 976\u2013978 (2012).","journal-title":"Autophagy"},{"key":"1105_CR85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cub.2012.02.005","volume":"22","author":"Q Cai","year":"2012","unstructured":"Cai, Q. et al. Spatial Parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr. Biol. 22, 545\u2013552 (2012).","journal-title":"Curr. Biol."},{"key":"1105_CR86","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1523\/JNEUROSCI.1198-15.2015","volume":"35","author":"S Devireddy","year":"2015","unstructured":"Devireddy, S. et al. The organization of mitochondrial quality control and life cycle in the nervous system in vivo in the absence of PINK1. J. Neurosci. 35, 9391\u20139401 (2015).","journal-title":"J. Neurosci."},{"key":"1105_CR87","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1523\/JNEUROSCI.0633-16.2016","volume":"36","author":"H Sung","year":"2016","unstructured":"Sung, H. et al. Compartmentalized regulation of Parkin-mediated mitochondrial quality control in the Drosophila nervous system in vivo. J. Neurosci. 36, 7375\u20137391 (2016).","journal-title":"J. Neurosci."},{"key":"1105_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11636-5","volume":"10","author":"R Puri","year":"2019","unstructured":"Puri, R. et al. Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts. Nat. Commun. 10, 3645 (2019).","journal-title":"Nat. Commun."},{"key":"1105_CR89","doi-asserted-by":"publisher","first-page":"113260","DOI":"10.1016\/j.celrep.2023.113260","volume":"42","author":"CS Waters","year":"2023","unstructured":"Waters, C. S. et al. A PINK1 input threshold arises from positive feedback in the PINK1\/Parkin mitophagy decision circuit. Cell Rep. 42, 113260 (2023).","journal-title":"Cell Rep."},{"key":"1105_CR90","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/hmg\/ddq531","volume":"20","author":"VS Van Laar","year":"2011","unstructured":"Van Laar, V. S. et al. Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum. Mol. Genet. 20, 927\u2013940 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR91","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1074\/jbc.M112.391680","volume":"288","author":"A Rakovic","year":"2013","unstructured":"Rakovic, A. et al. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons. J. Biol. Chem. 288, 2223\u20132237 (2013).","journal-title":"J. Biol. Chem."},{"key":"1105_CR92","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1080\/15548627.2021.1907167","volume":"17","author":"S Han","year":"2021","unstructured":"Han, S. et al. The role of mitophagy in the regulation of mitochondrial energetic status in neurons. Autophagy 17, 4182\u20134201 (2021).","journal-title":"Autophagy"},{"key":"1105_CR93","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1093\/hmg\/dds325","volume":"21","author":"AP Joselin","year":"2012","unstructured":"Joselin, A. P. et al. ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum. Mol. Genet. 21, 4888\u20134903 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR94","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1523\/JNEUROSCI.4441-10.2011","volume":"31","author":"P Seibler","year":"2011","unstructured":"Seibler, P. et al. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 31, 5970\u20135976 (2011).","journal-title":"J. Neurosci."},{"key":"1105_CR95","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","volume":"147","author":"X Wang","year":"2011","unstructured":"Wang, X. et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893\u2013906 (2011).","journal-title":"Cell"},{"key":"1105_CR96","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cbic.201700500","volume":"19","author":"E Barini","year":"2018","unstructured":"Barini, E. et al. The anthelmintic drug niclosamide and its analogues activate the Parkinson\u2019s disease associated protein kinase PINK1. ChemBioChem 19, 425\u2013429 (2018).","journal-title":"ChemBioChem"},{"key":"1105_CR97","doi-asserted-by":"publisher","first-page":"109336","DOI":"10.1016\/j.dib.2023.109336","volume":"49","author":"O Antico","year":"2023","unstructured":"Antico, O., Nirujogi, R. S. & Muqit, M. M. K. Whole proteome copy number dataset in primary mouse cortical neurons. Data Brief. 49, 109336 (2023).","journal-title":"Data Brief."},{"key":"1105_CR98","doi-asserted-by":"publisher","first-page":"19492","DOI":"10.1073\/pnas.0802280105","volume":"105","author":"TD Helton","year":"2008","unstructured":"Helton, T. D. et al. Pruning and loss of excitatory synapses by the Parkin ubiquitin ligase. Proc. Natl Acad. Sci. USA 105, 19492\u201319497 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR99","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1471-4159.2001.00364.x","volume":"78","author":"SI Kubo","year":"2001","unstructured":"Kubo, S. I. et al. Parkin is associated with cellular vesicles. J. Neurochem. 78, 42\u201354 (2001).","journal-title":"J. Neurochem."},{"key":"1105_CR100","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00702-004-0144-9","volume":"111","author":"A Mouatt-Prigent","year":"2004","unstructured":"Mouatt-Prigent, A. et al. Ultrastructural localization of Parkin in the rat brainstem, thalamus and basal ganglia. J. Neural Transm. 111, 1209\u20131218 (2004).","journal-title":"J. Neural Transm."},{"key":"1105_CR101","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1074\/jbc.M109806200","volume":"277","author":"L Fallon","year":"2002","unstructured":"Fallon, L. et al. Parkin and CASK\/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 277, 486\u2013491 (2002).","journal-title":"J. Biol. Chem."},{"key":"1105_CR102","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1016\/j.molcel.2021.10.001","volume":"81","author":"A Ordureau","year":"2021","unstructured":"Ordureau, A. et al. Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy. Mol. Cell 81, 5082\u20135098.e11 (2021).","journal-title":"Mol. Cell"},{"key":"1105_CR103","doi-asserted-by":"publisher","first-page":"eabn4705","DOI":"10.1126\/science.abn4705","volume":"379","author":"R Iwata","year":"2023","unstructured":"Iwata, R. et al. Mitochondria metabolism sets the species-specific tempo of neuronal development. Science 379, eabn4705 (2023).","journal-title":"Science"},{"key":"1105_CR104","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1083\/jcb.201401070","volume":"206","author":"G Ashrafi","year":"2014","unstructured":"Ashrafi, G. et al. Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and parkin. J. Cell Biol. 206, 655\u2013670 (2014).","journal-title":"J. Cell Biol."},{"key":"1105_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainres.2016.03.047","volume":"1649","author":"S Maday","year":"2016","unstructured":"Maday, S. Mechanisms of neuronal homeostasis: autophagy in the axon. Brain Res. 1649, 143\u2013150 (2016).","journal-title":"Brain Res."},{"key":"1105_CR106","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/15548627.2019.1618099","volume":"15","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y. et al. Come and eat: mitochondrial transport guides mitophagy in ischemic neuronal axons. Autophagy 15, 1483\u20131484 (2019).","journal-title":"Autophagy"},{"key":"1105_CR107","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1083\/jcb.201804101","volume":"218","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y. et al. Somatic autophagy of axonal mitochondria in ischemic neurons. J. Cell Biol. 218, 1891\u20131907 (2019).","journal-title":"J. Cell Biol."},{"key":"1105_CR108","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.neuron.2022.01.035","volume":"110","author":"AB Harbauer","year":"2022","unstructured":"Harbauer, A. B. et al. Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy. Neuron 110, 1516\u20131531 (2022).","journal-title":"Neuron"},{"key":"1105_CR109","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cmet.2017.12.008","volume":"27","author":"TG McWilliams","year":"2018","unstructured":"McWilliams, T. G. et al. Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand. Cell Metab. 27, 439\u2013449 (2018).","journal-title":"Cell Metab."},{"key":"1105_CR110","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67604","volume":"10","author":"F Singh","year":"2021","unstructured":"Singh, F. et al. Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice. eLife 10, e67604 (2021).","journal-title":"eLife"},{"key":"1105_CR111","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2015.10.009","volume":"60","author":"N Sun","year":"2015","unstructured":"Sun, N. et al. Measuring in vivo mitophagy. Mol. Cell 60, 685\u2013696 (2015).","journal-title":"Mol. Cell"},{"key":"1105_CR112","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang, E. F. et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat. Neurosci. 22, 401\u2013412 (2019).","journal-title":"Nat. Neurosci."},{"key":"1105_CR113","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-018-0044-6","volume":"4","author":"AK Reeve","year":"2018","unstructured":"Reeve, A. K. et al. Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson\u2019s disease. npj Parkinsons Dis. 4, 9 (2018).","journal-title":"npj Parkinsons Dis."},{"key":"1105_CR114","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949801","volume":"21","author":"S Han","year":"2020","unstructured":"Han, S., Jeong, Y. Y., Sheshadri, P., Su, X. & Cai, Q. Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance. EMBO Rep. 21, e49801 (2020).","journal-title":"EMBO Rep."},{"key":"1105_CR115","doi-asserted-by":"publisher","first-page":"10251","DOI":"10.3390\/ijms221910251","volume":"22","author":"V Sukhorukov","year":"2021","unstructured":"Sukhorukov, V. et al. Impaired mitophagy in neurons and glial cells during aging and age-related disorders. Int. J. Mol. Sci. 22, 10251 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1105_CR116","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cmet.2013.11.005","volume":"18","author":"E Motori","year":"2013","unstructured":"Motori, E. et al. Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. Cell Metab. 18, 844\u2013859 (2013).","journal-title":"Cell Metab."},{"key":"1105_CR117","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1016\/j.celrep.2019.10.130","volume":"29","author":"CE Wall","year":"2019","unstructured":"Wall, C. E. et al. PPEF2 opposes PINK1-mediated mitochondrial quality control by dephosphorylating ubiquitin. Cell Rep. 29, 3280\u20133292 (2019).","journal-title":"Cell Rep."},{"key":"1105_CR118","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1080\/15548627.2020.1871204","volume":"17","author":"M Yazdankhah","year":"2021","unstructured":"Yazdankhah, M. et al. BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes. Autophagy 17, 3140\u20133159 (2021).","journal-title":"Autophagy"},{"key":"1105_CR119","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41531-019-0101-9","volume":"5","author":"SK Barodia","year":"2019","unstructured":"Barodia, S. K. et al. PINK1 phosphorylates ubiquitin predominantly in astrocytes. npj Parkinsons Dis. 5, 29 (2019).","journal-title":"npj Parkinsons Dis."},{"key":"1105_CR120","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","volume":"623","author":"N Borcherding","year":"2023","unstructured":"Borcherding, N. & Brestoff, J. R. The power and potential of mitochondria transfer. Nature 623, 283\u2013291 (2023).","journal-title":"Nature"},{"key":"1105_CR121","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/glia.23839","volume":"68","author":"I Morales","year":"2020","unstructured":"Morales, I. et al. Neuroglial transmitophagy and Parkinson\u2019s disease. Glia 68, 2277\u20132299 (2020).","journal-title":"Glia"},{"key":"1105_CR122","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","volume":"112","author":"H Scheiblich","year":"2024","unstructured":"Scheiblich, H. et al. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes. Neuron 112, 3106\u20133125 (2024).","journal-title":"Neuron"},{"key":"1105_CR123","doi-asserted-by":"publisher","first-page":"105753","DOI":"10.1016\/j.nbd.2022.105753","volume":"170","author":"R Lampinen","year":"2022","unstructured":"Lampinen, R. et al. Neuron-astrocyte transmitophagy is altered in Alzheimer\u2019s disease. Neurobiol. Dis. 170, 105753 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1105_CR124","doi-asserted-by":"publisher","first-page":"168144","DOI":"10.1016\/j.jmb.2023.168144","volume":"435","author":"C Themistokleous","year":"2023","unstructured":"Themistokleous, C. et al. Role of autophagy pathway in Parkinson\u2019s disease and related genetic neurological disorders. J. Mol. Biol. 435, 168144 (2023).","journal-title":"J. Mol. Biol."},{"key":"1105_CR125","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente, E. M. et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304, 1158\u20131160 (2004).","journal-title":"Science"},{"key":"1105_CR126","doi-asserted-by":"crossref","unstructured":"Simons, E. & Fleming, S. M. Role of rodent models in advancing precision medicine for Parkinson\u2019s disease. In Handbook of Clinical Neurology (ed. Espay, A. J.) Ch. 1, 3\u201316 (Elsevier, 2023).","DOI":"10.1016\/B978-0-323-85555-6.00002-3"},{"key":"1105_CR127","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29985","volume":"6","author":"A Kumar","year":"2017","unstructured":"Kumar, A. et al. Structure of PINK1 and mechanisms of Parkinson\u2019s disease-associated mutations. eLife 6, e29985 (2017).","journal-title":"eLife"},{"key":"1105_CR128","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature24645","volume":"552","author":"AF Schubert","year":"2017","unstructured":"Schubert, A. F. et al. Structure of PINK1 in complex with its substrate ubiquitin. Nature 552, 51\u201356 (2017).","journal-title":"Nature"},{"key":"1105_CR129","doi-asserted-by":"publisher","first-page":"210264","DOI":"10.1098\/rsob.210264","volume":"12","author":"P Kakade","year":"2022","unstructured":"Kakade, P. et al. Mapping of a N-terminal \u03b1-helix domain required for human PINK1 stabilization, serine228 autophosphorylation and activation in cells. Open. Biol. 12, 210264 (2022).","journal-title":"Open. Biol."},{"key":"1105_CR130","doi-asserted-by":"publisher","first-page":"eadn7191","DOI":"10.1126\/sciadv.adn7191","volume":"10","author":"OG Raimi","year":"2024","unstructured":"Raimi, O. G. et al. Mechanism of human PINK1 activation at the TOM complex in a reconstituted system. Sci. Adv. 10, eadn7191 (2024).","journal-title":"Sci. Adv."},{"key":"1105_CR131","first-page":"a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein, C. & Westenberger, A. Genetics of Parkinson\u2019s disease. Cold Spring Harb. Persp. Med. 2, a008888 (2012).","journal-title":"Cold Spring Harb. Persp. Med."},{"key":"1105_CR132","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1098\/rsob.110012","volume":"1","author":"HI Woodroof","year":"2011","unstructured":"Woodroof, H. I. et al. Discovery of catalytically active orthologues of the Parkinson\u2019s disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open. Biol. 1, 110012 (2011).","journal-title":"Open. Biol."},{"key":"1105_CR133","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.20251","volume":"56","author":"Y Hatano","year":"2004","unstructured":"Hatano, Y. et al. Novel PINK1 mutations in early-onset parkinsonism. Ann. Neurol. 56, 424\u2013427 (2004).","journal-title":"Ann. Neurol."},{"key":"1105_CR134","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada, T. et al. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605\u2013608 (1998).","journal-title":"Nature"},{"key":"1105_CR135","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41531-024-00677-3","volume":"10","author":"PJ Menon","year":"2024","unstructured":"Menon, P. J. et al. Genotype\u2013phenotype correlation in PRKN-associated Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 10, 72 (2024).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"1105_CR136","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41380-023-02387-3","volume":"29","author":"D Hayek","year":"2024","unstructured":"Hayek, D. et al. Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition. Mol. Psychiatry 29, 992\u20131004 (2024).","journal-title":"Mol. Psychiatry"},{"key":"1105_CR137","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09966","volume":"474","author":"DM Wenzel","year":"2011","unstructured":"Wenzel, D. M. et al. UBCH7 reactivity profile reveals Parkin and HHARI to be RING\/HECT hybrids. Nature 474, 105\u2013108 (2011).","journal-title":"Nature"},{"key":"1105_CR138","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura, H. et al. Familial Parkinson disease gene product, Parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302\u2013305 (2000).","journal-title":"Nat. Genet."},{"key":"1105_CR139","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1126\/science.1237908","volume":"340","author":"JF Trempe","year":"2013","unstructured":"Trempe, J. F. et al. Structure of Parkin reveals mechanisms for ubiquitin ligase activation. Science 340, 1451\u20131455 (2013).","journal-title":"Science"},{"key":"1105_CR140","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/emboj.2013.125","volume":"32","author":"T Wauer","year":"2013","unstructured":"Wauer, T. & Komander, D. Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 32, 2099\u20132112 (2013).","journal-title":"EMBO J."},{"key":"1105_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2982","volume":"4","author":"BE Riley","year":"2013","unstructured":"Riley, B. E. et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun. 4, 1982 (2013).","journal-title":"Nat. Commun."},{"key":"1105_CR142","doi-asserted-by":"publisher","first-page":"939","DOI":"10.15252\/embr.201540352","volume":"16","author":"A Kazlauskaite","year":"2015","unstructured":"Kazlauskaite, A. et al. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep. 16, 939\u2013954 (2015).","journal-title":"EMBO Rep."},{"key":"1105_CR143","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.15252\/embj.201592337","volume":"34","author":"A Kumar","year":"2015","unstructured":"Kumar, A. et al. Disruption of the autoinhibited state primes the E3 ligase Parkin for activation and catalysis. EMBO J. 34, 2506\u20132521 (2015).","journal-title":"EMBO J."},{"key":"1105_CR144","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.15252\/embj.201592237","volume":"34","author":"V Sauve","year":"2015","unstructured":"Sauve, V. et al. A Ubl\/ubiquitin switch in the activation of Parkin. EMBO J. 34, 2492\u20132505 (2015).","journal-title":"EMBO J."},{"key":"1105_CR145","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100014","volume":"37","author":"TE Condos","year":"2018","unstructured":"Condos, T. E. et al. Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers Parkin activation. EMBO J. 37, e100014 (2018).","journal-title":"EMBO J."},{"key":"1105_CR146","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41594-018-0088-7","volume":"25","author":"V Sauve","year":"2018","unstructured":"Sauve, V. et al. Mechanism of Parkin activation by phosphorylation. Nat. Struct. Mol. Biol. 25, 623\u2013630 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1105_CR147","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nsmb.3400","volume":"24","author":"A Kumar","year":"2017","unstructured":"Kumar, A. et al. Parkin\u2013phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity. Nat. Struct. Mol. Biol. 24, 475\u2013483 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1105_CR148","doi-asserted-by":"publisher","first-page":"RP96699","DOI":"10.7554\/eLife.96699.3","volume":"13","author":"DR Lenka","year":"2024","unstructured":"Lenka, D. R. et al. Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans. eLife 13, RP96699 (2024).","journal-title":"eLife"},{"key":"1105_CR149","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1167\/iovs.04-0107","volume":"45","author":"CE Willoughby","year":"2004","unstructured":"Willoughby, C. E. et al. Defining the pathogenicity of optineurin in juvenile open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 45, 3122\u20133130 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1105_CR150","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature08971","volume":"465","author":"H Maruyama","year":"2010","unstructured":"Maruyama, H. et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223\u2013226 (2010).","journal-title":"Nature"},{"key":"1105_CR151","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygeno.2004.10.011","volume":"85","author":"T Rezaie","year":"2005","unstructured":"Rezaie, T. & Sarfarazi, M. Molecular cloning, genomic structure, and protein characterization of mouse optineurin. Genomics 85, 131\u2013138 (2005).","journal-title":"Genomics"},{"key":"1105_CR152","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/WCO.0000000000001294","volume":"37","author":"M Nijs","year":"2024","unstructured":"Nijs, M. & Van Damme, P. The genetics of amyotrophic lateral sclerosis. Curr. Opin. Neurol. 37, 560\u2013569 (2024).","journal-title":"Curr. Opin. Neurol."},{"key":"1105_CR153","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-12-394305-7.00005-7","volume":"294","author":"H Ying","year":"2012","unstructured":"Ying, H. & Yue, B. Y. Cellular and molecular biology of optineurin. Int. Rev. Cell Mol. Biol. 294, 223\u2013258 (2012).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"1105_CR154","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3389\/fimmu.2018.01024","volume":"9","author":"TA Ryan","year":"2018","unstructured":"Ryan, T. A. & Tumbarello, D. A. Optineurin: a coordinator of membrane-associated cargo trafficking and autophagy. Front. Immunol. 9, 1024 (2018).","journal-title":"Front. Immunol."},{"key":"1105_CR155","doi-asserted-by":"publisher","first-page":"1016 e1","DOI":"10.1016\/j.neurobiolaging.2011.05.019","volume":"33","author":"M van Blitterswijk","year":"2012","unstructured":"van Blitterswijk, M. et al. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging 33, 1016 e1\u20131016 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1105_CR156","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/15548627.2017.1391970","volume":"14","author":"F Li","year":"2018","unstructured":"Li, F. et al. Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation. Autophagy 14, 66\u201379 (2018).","journal-title":"Autophagy"},{"key":"1105_CR157","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1167\/iovs.19-27184","volume":"60","author":"K Chernyshova","year":"2019","unstructured":"Chernyshova, K. et al. Glaucoma-associated mutations in the optineurin gene have limited impact on parkin-dependent mitophagy. Invest. Ophthalmol. Vis. Sci. 60, 3625\u20133635 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1105_CR158","doi-asserted-by":"publisher","first-page":"E3349","DOI":"10.1073\/pnas.1523810113","volume":"113","author":"AS Moore","year":"2016","unstructured":"Moore, A. S. & Holzbaur, E. L. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc. Natl Acad. Sci. USA 113, E3349\u2013E3358 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR159","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.molcel.2023.04.021","volume":"83","author":"TN Nguyen","year":"2023","unstructured":"Nguyen, T. N. et al. Unconventional initiation of PINK1\/Parkin mitophagy by optineurin. Mol. Cell 83, 1693\u20131709 (2023).","journal-title":"Mol. Cell"},{"key":"1105_CR160","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/s41594-024-01338-y","volume":"31","author":"E Adriaenssens","year":"2024","unstructured":"Adriaenssens, E. et al. Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD. Nat. Struct. Mol. Biol. 31, 1717\u20131731 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1105_CR161","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli, E. T. et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436\u20131441 (2015).","journal-title":"Science"},{"key":"1105_CR162","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","volume":"18","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt, A. et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631\u2013636 (2015).","journal-title":"Nat. Neurosci."},{"key":"1105_CR163","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00401-015-1436-x","volume":"130","author":"C Pottier","year":"2015","unstructured":"Pottier, C. et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130, 77\u201392 (2015).","journal-title":"Acta Neuropathol."},{"key":"1105_CR164","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1073\/pnas.1523926113","volume":"113","author":"B Richter","year":"2016","unstructured":"Richter, B. et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl Acad. Sci. USA 113, 4039\u20134044 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR165","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1093\/hmg\/ddv179","volume":"24","author":"G Matsumoto","year":"2015","unstructured":"Matsumoto, G. et al. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62\/SQSTM1 phosphorylation. Hum. Mol. Genet. 24, 4429\u20134442 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR166","doi-asserted-by":"publisher","first-page":"24517","DOI":"10.1073\/pnas.1915732116","volume":"116","author":"J Ye","year":"2019","unstructured":"Ye, J. et al. Effects of ALS-associated TANK binding kinase 1 mutations on protein\u2013protein interactions and kinase activity. Proc. Natl Acad. Sci. USA 116, 24517\u201324526 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR167","doi-asserted-by":"publisher","first-page":"266 e1","DOI":"10.1016\/j.neurobiolaging.2018.06.015","volume":"71","author":"M de Majo","year":"2018","unstructured":"de Majo, M. et al. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol. Aging 71, 266 e1\u2013266 (2018).","journal-title":"Neurobiol. Aging"},{"key":"1105_CR168","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025053118","volume":"118","author":"O Harding","year":"2021","unstructured":"Harding, O. et al. ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy. Proc. Natl Acad. Sci. USA 118, e2025053118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR169","first-page":"1403","volume":"70","author":"I Le Ber","year":"2013","unstructured":"Le Ber, I. et al. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 70, 1403\u20131410 (2013).","journal-title":"JAMA Neurol."},{"key":"1105_CR170","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","volume":"68","author":"F Fecto","year":"2011","unstructured":"Fecto, F. et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440\u20131446 (2011).","journal-title":"Arch. Neurol."},{"key":"1105_CR171","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1212\/WNL.0b013e31827f0fe5","volume":"80","author":"M Hirano","year":"2013","unstructured":"Hirano, M. et al. Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology 80, 458\u2013463 (2013).","journal-title":"Neurology"},{"key":"1105_CR172","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1212\/WNL.0b013e31826e25df","volume":"79","author":"E Rubino","year":"2012","unstructured":"Rubino, E. et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79, 1556\u20131562 (2012).","journal-title":"Neurology"},{"key":"1105_CR173","doi-asserted-by":"publisher","first-page":"105653","DOI":"10.1016\/j.nbd.2022.105653","volume":"166","author":"JM Davidson","year":"2022","unstructured":"Davidson, J. M., Chung, R. S. & Lee, A. The converging roles of sequestosome-1\/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Neurobiol. Dis. 166, 105653 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1105_CR174","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-014-1298-7","volume":"128","author":"J van der Zee","year":"2014","unstructured":"van der Zee, J. et al. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 128, 397\u2013410 (2014).","journal-title":"Acta Neuropathol."},{"key":"1105_CR175","doi-asserted-by":"publisher","first-page":"793328","DOI":"10.3389\/fcell.2022.793328","volume":"10","author":"AV Kumar","year":"2022","unstructured":"Kumar, A. V., Mills, J. & Lapierre, L. R. Selective autophagy receptor p62\/SQSTM1, a pivotal player in stress and aging. Front. Cell Dev. Biol. 10, 793328 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1105_CR176","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.stemcr.2019.01.023","volume":"12","author":"J Calvo-Garrido","year":"2019","unstructured":"Calvo-Garrido, J. et al. SQSTM1\/p62-directed metabolic reprogramming is essential for normal neurodifferentiation. Stem Cell Rep. 12, 696\u2013711 (2019).","journal-title":"Stem Cell Rep."},{"key":"1105_CR177","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.stemcr.2021.03.030","volume":"16","author":"A Poon","year":"2021","unstructured":"Poon, A. et al. The role of SQSTM1 (p62) in mitochondrial function and clearance in human cortical neurons. Stem Cell Rep. 16, 1276\u20131289 (2021).","journal-title":"Stem Cell Rep."},{"key":"1105_CR178","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ncb2407","volume":"14","author":"H Meyer","year":"2012","unstructured":"Meyer, H., Bug, M. & Bremer, S. Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14, 117\u2013123 (2012).","journal-title":"Nat. Cell Biol."},{"key":"1105_CR179","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson, J. O. et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857\u2013864 (2010).","journal-title":"Neuron"},{"key":"1105_CR180","doi-asserted-by":"publisher","first-page":"105722","DOI":"10.1016\/j.nbd.2022.105722","volume":"169","author":"MA Johnson","year":"2022","unstructured":"Johnson, M. A. et al. The cure VCP scientific conference 2021: molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1). Neurobiol. Dis. 169, 105722 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1105_CR181","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molcel.2017.10.028","volume":"69","author":"J van den Boom","year":"2018","unstructured":"van den Boom, J. & Meyer, H. VCP\/p97-mediated unfolding as a principle in protein homeostasis and signaling. Mol. Cell 69, 182\u2013194 (2018).","journal-title":"Mol. Cell"},{"key":"1105_CR182","doi-asserted-by":"publisher","first-page":"2231.e1","DOI":"10.1016\/j.neurobiolaging.2012.04.005","volume":"33","author":"Y Abramzon","year":"2012","unstructured":"Abramzon, Y. et al. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33, 2231.e1\u20132231.e6 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1105_CR183","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/15548627.2021.1922982","volume":"18","author":"C Mengus","year":"2022","unstructured":"Mengus, C. et al. VCP\/p97 cofactor UBXN1\/SAKS1 regulates mitophagy by modulating MFN2 removal from mitochondria. Autophagy 18, 171\u2013190 (2022).","journal-title":"Autophagy"},{"key":"1105_CR184","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.3390\/ijms21186841","volume":"21","author":"M Escobar-Henriques","year":"2020","unstructured":"Escobar-Henriques, M. & Anton, V. Mitochondrial surveillance by Cdc48\/p97: MAD vs. membrane fusion. Int. J. Mol. Sci. 21, 6841 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1105_CR185","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2013.02.028","volume":"78","author":"F Bartolome","year":"2013","unstructured":"Bartolome, F. et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 78, 57\u201364 (2013).","journal-title":"Neuron"},{"key":"1105_CR186","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuron.2013.02.029","volume":"78","author":"NC Kim","year":"2013","unstructured":"Kim, N. C. et al. VCP is essential for mitochondrial quality control by PINK1\/Parkin and this function is impaired by VCP mutations. Neuron 78, 65\u201380 (2013).","journal-title":"Neuron"},{"key":"1105_CR187","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17834","volume":"6","author":"T Zhang","year":"2017","unstructured":"Zhang, T., Mishra, P., Hay, B. A., Chan, D. & Guo, M. Valosin-containing protein (VCP\/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants. eLife 6, e17834 (2017).","journal-title":"eLife"},{"key":"1105_CR188","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.1074\/jbc.M116.762898","volume":"292","author":"MHR Ludtmann","year":"2017","unstructured":"Ludtmann, M. H. R. et al. Mutations in valosin-containing protein (VCP) decrease ADP\/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons. J. Biol. Chem. 292, 8907\u20138917 (2017).","journal-title":"J. Biol. Chem."},{"key":"1105_CR189","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1080\/15548627.2022.2052461","volume":"18","author":"G Lu","year":"2022","unstructured":"Lu, G. et al. WIPI2 positively regulates mitophagy by promoting mitochondrial recruitment of VCP. Autophagy 18, 2865\u20132879 (2022).","journal-title":"Autophagy"},{"key":"1105_CR190","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1083\/jcb.201007013","volume":"191","author":"A Tanaka","year":"2010","unstructured":"Tanaka, A. et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191, 1367\u20131380 (2010).","journal-title":"J. Cell Biol."},{"key":"1105_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30963-z","volume":"8","author":"AC Bento","year":"2018","unstructured":"Bento, A. C. et al. UBXD1 is a mitochondrial recruitment factor for p97\/VCP and promotes mitophagy. Sci. Rep. 8, 12415 (2018).","journal-title":"Sci. Rep."},{"key":"1105_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13047","volume":"7","author":"A Arumughan","year":"2016","unstructured":"Arumughan, A. et al. Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers. Nat. Commun. 7, 13047 (2016).","journal-title":"Nat. Commun."},{"key":"1105_CR193","doi-asserted-by":"publisher","unstructured":"Smeland, O. B. et al. The shared genetic risk architecture of neurological and psychiatric disorders: a genome-wide analysis. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2023.07.21.23292993 (2023).","DOI":"10.1101\/2023.07.21.23292993"},{"key":"1105_CR194","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1212\/WNL.0000000000200699","volume":"99","author":"S Grover","year":"2022","unstructured":"Grover, S. et al. Genome-wide association and meta-analysis of age at onset in Parkinson disease: evidence from the COURAGE-PD consortium. Neurology 99, e698\u2013e710 (2022).","journal-title":"Neurology"},{"key":"1105_CR195","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-191854","volume":"10","author":"International Parkinson Disease Genomics Consortium.","year":"2020","unstructured":"International Parkinson Disease Genomics Consortium. Ten years of the International Parkinson Disease Genomics Consortium: progress and next steps. J. Parkinsons Dis. 10, 19\u201330 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1105_CR196","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"JJ Kim","year":"2024","unstructured":"Kim, J. J. et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat. Genet. 56, 27\u201336 (2024).","journal-title":"Nat. Genet."},{"key":"1105_CR197","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1093\/brain\/awac325","volume":"145","author":"MPM Soutar","year":"2022","unstructured":"Soutar, M. P. M. et al. Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson\u2019s disease at 16q11.2 and MAPT H1 loci. Brain 145, 4349\u20134367 (2022).","journal-title":"Brain"},{"key":"1105_CR198","doi-asserted-by":"publisher","first-page":"8494","DOI":"10.1073\/pnas.1321207111","volume":"111","author":"RM Ivatt","year":"2014","unstructured":"Ivatt, R. M. et al. Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy. Proc. Natl Acad. Sci. USA 111, 8494\u20138499 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR199","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002141","volume":"7","author":"CB Do","year":"2011","unstructured":"Do, C. B. et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson\u2019s disease. PLoS Genet. 7, e1002141 (2011).","journal-title":"PLoS Genet."},{"key":"1105_CR200","doi-asserted-by":"publisher","unstructured":"Hou, X. et al. Genome-wide association study identifies APOE and ZMIZ1 variants as mitophagy modifiers in Lewy body disease. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2023.10.16.23297100 (2023).","DOI":"10.1101\/2023.10.16.23297100"},{"key":"1105_CR201","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"1105_CR202","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. et al. APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91, e1182\u2013e1195 (2018).","journal-title":"Neurology"},{"key":"1105_CR203","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbrc.2016.12.188","volume":"483","author":"S Suzuki","year":"2017","unstructured":"Suzuki, S. et al. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons. Biochem. Biophys. Res. Commun. 483, 88\u201393 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1105_CR204","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fncel.2019.00297","volume":"13","author":"H Bogetofte","year":"2019","unstructured":"Bogetofte, H. et al. PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons. Front. Cell Neurosci. 13, 297 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"1105_CR205","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.stemcr.2021.04.022","volume":"16","author":"J Okarmus","year":"2021","unstructured":"Okarmus, J. et al. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: altered mitochondrial and energy metabolism. Stem Cell Rep. 16, 1510\u20131526 (2021).","journal-title":"Stem Cell Rep."},{"key":"1105_CR206","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1016\/j.neuron.2023.08.018","volume":"111","author":"P Song","year":"2023","unstructured":"Song, P. et al. Parkinson\u2019s disease-linked Parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons. Neuron 111, 3775\u20133788 (2023).","journal-title":"Neuron"},{"key":"1105_CR207","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1074\/jbc.RA117.000499","volume":"293","author":"N Giguere","year":"2018","unstructured":"Giguere, N. et al. Comparative analysis of Parkinson\u2019s disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons. J. Biol. Chem. 293, 9580\u20139593 (2018).","journal-title":"J. Biol. Chem."},{"key":"1105_CR208","doi-asserted-by":"publisher","first-page":"104717","DOI":"10.1016\/j.nbd.2019.104717","volume":"136","author":"S Noda","year":"2020","unstructured":"Noda, S. et al. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. Neurobiol. Dis. 136, 104717 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1105_CR209","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/hmg\/ddm083","volume":"16","author":"CC Stichel","year":"2007","unstructured":"Stichel, C. C. et al. Mono- and double-mutant mouse models of Parkinson\u2019s disease display severe mitochondrial damage. Hum. Mol. Genet. 16, 2377\u20132393 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR210","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.0409598102","volume":"102","author":"FA Perez","year":"2005","unstructured":"Perez, F. A. & Palmiter, R. D. Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl Acad. Sci. USA 102, 2174\u20132179 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR211","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/jnr.21032","volume":"84","author":"S Sato","year":"2006","unstructured":"Sato, S. et al. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography. J. Neurosci. Res. 84, 1350\u20131357 (2006).","journal-title":"J. Neurosci. Res."},{"key":"1105_CR212","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg, M. S. et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628\u201343635 (2003).","journal-title":"J. Biol. Chem."},{"key":"1105_CR213","doi-asserted-by":"publisher","first-page":"12937","DOI":"10.1073\/pnas.1103295108","volume":"108","author":"FH Sterky","year":"2011","unstructured":"Sterky, F. H. et al. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl Acad. Sci. USA 108, 12937\u201312942 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR214","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neuron.2015.06.034","volume":"87","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. et al. Endogenous Parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron 87, 371\u2013381 (2015).","journal-title":"Neuron"},{"key":"1105_CR215","doi-asserted-by":"publisher","first-page":"9263","DOI":"10.1523\/JNEUROSCI.0545-22.2022","volume":"42","author":"L Scott","year":"2022","unstructured":"Scott, L. et al. The absence of Parkin does not promote dopamine or mitochondrial dysfunction in PolgA(D257A\/D257A) mitochondrial mutator mice. J. Neurosci. 42, 9263\u20139277 (2022).","journal-title":"J. Neurosci."},{"key":"1105_CR216","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.3390\/ijms25126441","volume":"25","author":"AJ Trease","year":"2024","unstructured":"Trease, A. J. et al. Mitochondrial DNA instability supersedes Parkin mutations in driving mitochondrial proteomic alterations and functional deficits in Polg mutator mice. Int. J. Mol. Sci. 25, 6441 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1105_CR217","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7150\/ijbs.3.242","volume":"3","author":"H Zhou","year":"2007","unstructured":"Zhou, H. et al. Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int. J. Biol. Sci. 3, 242\u2013250 (2007).","journal-title":"Int. J. Biol. Sci."},{"key":"1105_CR218","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.1073\/pnas.0702717104","volume":"104","author":"T Kitada","year":"2007","unstructured":"Kitada, T. et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl Acad. Sci. USA 104, 11441\u201311446 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR219","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JPD-2011-11041","volume":"1","author":"M Oliveras-Salva","year":"2011","unstructured":"Oliveras-Salva, M. et al. Loss-of-function rodent models for Parkin and PINK1. J. Parkinsons Dis. 1, 229\u2013251 (2011).","journal-title":"J. Parkinsons Dis."},{"key":"1105_CR220","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005777","volume":"4","author":"S Gispert","year":"2009","unstructured":"Gispert, S. et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS ONE 4, e5777 (2009).","journal-title":"PLoS ONE"},{"key":"1105_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2017.12.002","volume":"1680","author":"CA Kelm-Nelson","year":"2018","unstructured":"Kelm-Nelson, C. A. et al. Characterization of early-onset motor deficits in the Pink1\u2013\/\u2013 mouse model of Parkinson disease. Brain Res. 1680, 1\u201312 (2018).","journal-title":"Brain Res."},{"key":"1105_CR222","doi-asserted-by":"publisher","first-page":"105246","DOI":"10.1016\/j.nbd.2020.105246","volume":"150","author":"RB Creed","year":"2021","unstructured":"Creed, R. B. et al. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats. Neurobiol. Dis. 150, 105246 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1105_CR223","doi-asserted-by":"publisher","first-page":"100656","DOI":"10.1016\/j.bbih.2023.100656","volume":"31","author":"BG Lamberty","year":"2023","unstructured":"Lamberty, B. G. et al. Parkinson\u2019s disease relevant pathological features are manifested in male Pink1\/Parkin deficient rats. Brain Behav. Immun. Health 31, 100656 (2023).","journal-title":"Brain Behav. Immun. Health"},{"key":"1105_CR224","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.35878","volume":"7","author":"T Cornelissen","year":"2018","unstructured":"Cornelissen, T. et al. Deficiency of Parkin and PINK1 impairs age-dependent mitophagy in Drosophila. eLife 7, e35878 (2018).","journal-title":"eLife"},{"key":"1105_CR225","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1042\/BCJ20210508","volume":"478","author":"E Tsefou","year":"2021","unstructured":"Tsefou, E. et al. Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches. Biochem. J. 478, 4099\u20134118 (2021).","journal-title":"Biochem. J."},{"key":"1105_CR226","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101287","volume":"5","author":"EV Rusilowicz-Jones","year":"2022","unstructured":"Rusilowicz-Jones, E. V. et al. Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy. Life Sci. Alliance 5, e202101287 (2022).","journal-title":"Life Sci. Alliance"},{"key":"1105_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06439-6","volume":"15","author":"J Okarmus","year":"2024","unstructured":"Okarmus, J. et al. USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient human neurons. Cell Death Dis. 15, 52 (2024).","journal-title":"Cell Death Dis."},{"key":"1105_CR228","doi-asserted-by":"publisher","first-page":"947191","DOI":"10.3389\/fnmol.2022.947191","volume":"15","author":"NJ Thorne","year":"2022","unstructured":"Thorne, N. J. & Tumbarello, D. A. The relationship of \u03b1-synuclein to mitochondrial dynamics and quality control. Front. Mol. Neurosci. 15, 947191 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"1105_CR229","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","volume":"7","author":"SunY Chung","year":"2016","unstructured":"Chung, SunY. et al. Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and \u03b1-synuclein accumulation. Stem Cell Rep. 7, 664\u2013677 (2016).","journal-title":"Stem Cell Rep."},{"key":"1105_CR230","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2020.04.032","volume":"437","author":"RB Creed","year":"2020","unstructured":"Creed, R. B. & Goldberg, M. S. Enhanced susceptibility of PINK1 knockout rats to \u03b1-synuclein fibrils. NeuroScience 437, 64\u201375 (2020).","journal-title":"NeuroScience"},{"key":"1105_CR231","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41531-024-00696-0","volume":"10","author":"I Kinnart","year":"2024","unstructured":"Kinnart, I. et al. Elevated \u03b1-synuclein levels inhibit mitophagic flux. npj Parkinson\u2019s Dis. 10, 80 (2024).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"1105_CR232","doi-asserted-by":"publisher","first-page":"9032","DOI":"10.1007\/s12035-024-04131-6","volume":"61","author":"S Hui","year":"2024","unstructured":"Hui, S. et al. Mitophagy upregulation occurs early in the neurodegenerative process mediated by \u03b1-synuclein. Mol. Neurobiol. 61, 9032\u20139042 (2024).","journal-title":"Mol. Neurobiol."},{"key":"1105_CR233","doi-asserted-by":"publisher","unstructured":"Chin, R. M. et al. Pharmacological PINK1 activation ameliorates pathology in Parkinson\u2019s disease models. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.02.14.528378 (2023).","DOI":"10.1101\/2023.02.14.528378"},{"key":"1105_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47027-8","volume":"15","author":"TM Goralski","year":"2024","unstructured":"Goralski, T. M. et al. Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nat. Commun. 15, 2642 (2024).","journal-title":"Nat. Commun."},{"key":"1105_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42876-1","volume":"14","author":"T-SZ Fang","year":"2023","unstructured":"Fang, T.-S. Z. et al. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson\u2019s disease mouse model. Nat. Commun. 14, 7295 (2023).","journal-title":"Nat. Commun."},{"key":"1105_CR236","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.29025","volume":"37","author":"K Wasner","year":"2022","unstructured":"Wasner, K. et al. Parkin deficiency impairs mitochondrial DNA dynamics and propagates inflammation. Mov. Disord. 37, 1405\u20131415 (2022).","journal-title":"Mov. Disord."},{"key":"1105_CR237","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1093\/brain\/awac464","volume":"146","author":"J Trinh","year":"2023","unstructured":"Trinh, J. et al. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1\/PRKN-linked Parkinson\u2019s disease. Brain 146, 2753\u20132765 (2023).","journal-title":"Brain"},{"key":"1105_CR238","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi, S. et al. Mitochondrial control of inflammation. Nat. Rev. Immunol. 23, 159\u2013173 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1105_CR239","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","volume":"561","author":"DA Sliter","year":"2018","unstructured":"Sliter, D. A. et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258\u2013262 (2018).","journal-title":"Nature"},{"key":"1105_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59647-3","volume":"10","author":"JJ Lee","year":"2020","unstructured":"Lee, J. J., Andreazza, S. & Whitworth, A. J. The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1\/Parkin or mtDNA mutator models. Sci. Rep. 10, 2693 (2020).","journal-title":"Sci. Rep."},{"key":"1105_CR241","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1007\/s12035-019-01665-y","volume":"56","author":"P Martin-Maestro","year":"2019","unstructured":"Martin-Maestro, P. et al. Autophagy induction by bexarotene promotes mitophagy in presenilin 1 familial Alzheimer\u2019s disease iPSC-derived neural stem cells. Mol. Neurobiol. 56, 8220\u20138236 (2019).","journal-title":"Mol. Neurobiol."},{"key":"1105_CR242","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/brain\/awx258","volume":"140","author":"F Du","year":"2017","unstructured":"Du, F. et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer\u2019s disease. Brain 140, 3233\u20133251 (2017).","journal-title":"Brain"},{"key":"1105_CR243","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings, L. M. et al. Intraneuronal A\u03b2 causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron 45, 675\u2013688 (2005).","journal-title":"Neuron"},{"key":"1105_CR244","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"1105_CR245","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/hmg\/ddr091","volume":"20","author":"PJ Khandelwal","year":"2011","unstructured":"Khandelwal, P. J. et al. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated A\u03b2 in AD models. Hum. Mol. Genet. 20, 2091\u20132102 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR246","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/hmg\/ddv616","volume":"25","author":"P Martin-Maestro","year":"2016","unstructured":"Martin-Maestro, P. et al. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer\u2019s disease. Hum. Mol. Genet. 25, 792\u2013806 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR247","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fnmol.2017.00291","volume":"10","author":"P Martin-Maestro","year":"2017","unstructured":"Martin-Maestro, P. et al. Mitophagy failure in fibroblasts and iPSC-derived neurons of Alzheimer\u2019s disease-associated presenilin 1 mutation. Front. Mol. Neurosci. 10, 291 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"1105_CR248","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot, L. et al. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol. 141, 39\u201365 (2021).","journal-title":"Acta Neuropathol."},{"key":"1105_CR249","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature25143","volume":"552","author":"V Sorrentino","year":"2017","unstructured":"Sorrentino, V. et al. Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity. Nature 552, 187\u2013193 (2017).","journal-title":"Nature"},{"key":"1105_CR250","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","volume":"11","author":"I Lefterov","year":"2019","unstructured":"Lefterov, I. et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Alzheimers Res. Ther. 11, 113 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"1105_CR251","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuron.2015.06.026","volume":"87","author":"Y Xie","year":"2015","unstructured":"Xie, Y. et al. Endolysosomal deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice. Neuron 87, 355\u2013370 (2015).","journal-title":"Neuron"},{"key":"1105_CR252","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.3390\/ijms21207525","volume":"21","author":"YJ Tak","year":"2020","unstructured":"Tak, Y. J. et al. ALS-related mutant SOD1 aggregates interfere with mitophagy by sequestering the autophagy receptor optineurin. Int. J. Mol. Sci. 21, 7525 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1105_CR253","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nn.3230","volume":"15","author":"C Lagier-Tourenne","year":"2012","unstructured":"Lagier-Tourenne, C. et al. Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 1488\u20131497 (2012).","journal-title":"Nat. Neurosci."},{"key":"1105_CR254","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1093\/hmg\/ddx348","volume":"26","author":"A Moller","year":"2017","unstructured":"Moller, A. et al. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum. Mol. Genet. 26, 4668\u20134679 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1105_CR255","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201808888","volume":"10","author":"GM Palomo","year":"2018","unstructured":"Palomo, G. M. et al. Parkin is a disease modifier in the mutant SOD1 mouse model of ALS. EMBO Mol. Med. 10, e8888 (2018).","journal-title":"EMBO Mol. Med."},{"key":"1105_CR256","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fnins.2017.00473","volume":"11","author":"RS Rogers","year":"2017","unstructured":"Rogers, R. S. et al. Impaired mitophagy plays a role in denervation of neuromuscular junctions in ALS mice. Front. Neurosci. 11, 473 (2017).","journal-title":"Front. Neurosci."},{"key":"1105_CR257","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081272","volume":"11","author":"M Bordoni","year":"2022","unstructured":"Bordoni, M. et al. Lysosomes dysfunction causes mitophagy impairment in PBMCs of sporadic ALS patients. Cells 11, e8888 (2022).","journal-title":"Cells"},{"key":"1105_CR258","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","volume":"13","author":"M Martinez-Vicente","year":"2010","unstructured":"Martinez-Vicente, M. et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease. Nat. Neurosci. 13, 567\u2013576 (2010).","journal-title":"Nat. Neurosci."},{"key":"1105_CR259","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/15548627.2020.1728096","volume":"17","author":"S Franco-Iborra","year":"2021","unstructured":"Franco-Iborra, S. et al. Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. Autophagy 17, 672\u2013689 (2021).","journal-title":"Autophagy"},{"key":"1105_CR260","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.581","volume":"6","author":"B Khalil","year":"2015","unstructured":"Khalil, B. et al. PINK1-induced mitophagy promotes neuroprotection in Huntington\u2019s disease. Cell Death Dis. 6, e1617 (2015).","journal-title":"Cell Death Dis."},{"key":"1105_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12646","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo, X. et al. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease. Nat. Commun. 7, 12646 (2016).","journal-title":"Nat. Commun."},{"key":"1105_CR262","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/acs.jmedchem.2c01092","volume":"66","author":"E Pol\u00e1chov\u00e1","year":"2023","unstructured":"Pol\u00e1chov\u00e1, E. et al. Chemical blockage of the mitochondrial rhomboid protease PARL by novel ketoamide inhibitors reveals its role in PINK1\/parkin-dependent mitophagy. J. Med. Chem. 66, 251\u2013265 (2023).","journal-title":"J. Med. Chem."},{"key":"1105_CR263","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809014","volume":"10","author":"J Chakraborty","year":"2018","unstructured":"Chakraborty, J. et al. USP14 inhibition corrects an in vivo model of impaired mitophagy. EMBO Mol. Med. 10, e9014 (2018).","journal-title":"EMBO Mol. Med."},{"key":"1105_CR264","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature09299","volume":"467","author":"BH Lee","year":"2010","unstructured":"Lee, B. H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179\u2013184 (2010).","journal-title":"Nature"},{"key":"1105_CR265","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-018-0056-0","volume":"28","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1\u2013Parkin-mediated mitophagy. Cell Res. 28, 787\u2013802 (2018).","journal-title":"Cell Res."},{"key":"1105_CR266","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nsmb.3469","volume":"24","author":"Y Sato","year":"2017","unstructured":"Sato, Y. et al. Structural basis for specific cleavage of Lys6-linked polyubiquitin chains by USP30. Nat. Struct. Mol. Biol. 24, 911\u2013919 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1105_CR267","first-page":"523","volume":"32","author":"SF Cabrera","year":"2021","unstructured":"Cabrera, S. F., Muratore, M. E. & Buijnsters, P. The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013. Exp. Opin. Ther. Pat. 32, 523\u2013559 (2021).","journal-title":"Exp. Opin. Ther. Pat."},{"key":"1105_CR268","doi-asserted-by":"publisher","first-page":"100609","DOI":"10.1016\/j.mcpro.2023.100609","volume":"22","author":"DP O\u2019Brien","year":"2023","unstructured":"O\u2019Brien, D. P. et al. Structural premise of selective deubiquitinase USP30 inhibition by small-molecule benzosulfonamides. Mol. Cell. Proteom. 22, 100609 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"1105_CR269","doi-asserted-by":"publisher","unstructured":"O\u2019Brien, D. P. et al. Structural dynamics of the ubiquitin specific protease USP30 in complex with a cyanopyrrolidine-containing covalent inhibitor. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.20.604388 (2024).","DOI":"10.1101\/2024.07.20.604388"},{"key":"1105_CR270","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ana.26917","volume":"95","author":"A Kluge","year":"2024","unstructured":"Kluge, A. et al. \u03b1\u2010synuclein pathology in PRKN\u2010linked Parkinson\u2019s disease: new insights from a blood\u2010based seed amplification assay. Ann. Neurol. 95, 1173\u20131177 (2024).","journal-title":"Ann. Neurol."},{"key":"1105_CR271","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.bmcl.2018.05.013","volume":"28","author":"AF Kluge","year":"2018","unstructured":"Kluge, A. F. et al. Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy. Bioorg. Med. Chem. Lett. 28, 2655\u20132659 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1105_CR272","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cell.2013.07.030","volume":"154","author":"NT Hertz","year":"2013","unstructured":"Hertz, N. T. et al. A neo-substrate that amplifies catalytic activity of Parkinson\u2019s-disease-related kinase PINK1. Cell 154, 737\u2013747 (2013).","journal-title":"Cell"},{"key":"1105_CR273","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1021\/acs.jmedchem.6b01897","volume":"60","author":"L Osgerby","year":"2017","unstructured":"Osgerby, L. et al. Kinetin riboside and its protides activate the Parkinson\u2019s disease associated PTEN-induced putative kinase 1 (PINK1) independent of mitochondrial depolarization. J. Med. Chem. 60, 3518\u20133524 (2017).","journal-title":"J. Med. Chem."},{"key":"1105_CR274","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119009119","volume":"119","author":"PI Tsai","year":"2022","unstructured":"Tsai, P. I., Korotkevich, E. & O\u2019Farrell, P. H. Mitigation of age-dependent accumulation of defective mitochondrial genomes. Proc. Natl Acad. Sci. USA 119, e2119009119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR275","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuint.2017.04.006","volume":"109","author":"AL Orr","year":"2017","unstructured":"Orr, A. L. et al. Long-term oral kinetin does not protect against \u03b1-synuclein-induced neurodegeneration in rodent models of Parkinson\u2019s disease. Neurochem. Int. 109, 106\u2013116 (2017).","journal-title":"Neurochem. Int."},{"key":"1105_CR276","doi-asserted-by":"publisher","first-page":"eadj7408","DOI":"10.1126\/sciadv.adj7408","volume":"10","author":"ZY Gan","year":"2024","unstructured":"Gan, Z. Y. et al. Interaction of PINK1 with nucleotides and kinetin. Sci. Adv. 10, eadj7408 (2024).","journal-title":"Sci. Adv."},{"key":"1105_CR277","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/10409238.2018.1491525","volume":"53","author":"S Rasool","year":"2018","unstructured":"Rasool, S. & Trempe, J. F. New insights into the structure of PINK1 and the mechanism of ubiquitin phosphorylation. Crit. Rev. Biochem. Mol. Biol. 53, 515\u2013534 (2018).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"1105_CR278","doi-asserted-by":"publisher","first-page":"103650","DOI":"10.1016\/j.isci.2021.103650","volume":"25","author":"E Shlevkov","year":"2022","unstructured":"Shlevkov, E. et al. Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase. iScience 25, 103650 (2022).","journal-title":"iScience"},{"key":"1105_CR279","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.crmeth.2024.100712","volume":"4","author":"R Traynor","year":"2024","unstructured":"Traynor, R. et al. Design and high-throughput implementation of MALDI-TOF\/MS-based assays for Parkin E3 ligase activity. Cell Rep. Methods 4, 100712 (2024).","journal-title":"Cell Rep. Methods"},{"key":"1105_CR280","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51889-3","volume":"15","author":"V Sauve","year":"2024","unstructured":"Sauve, V. et al. Activation of Parkin by a molecular glue. Nat. Commun. 15, 7707 (2024).","journal-title":"Nat. Commun."},{"key":"1105_CR281","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.str.2024.09.012","volume":"32","author":"DR Lenka","year":"2024","unstructured":"Lenka, D. R. et al. Mechanism of phospho-Ubls\u2019 specificity and conformational changes that regulate Parkin activity. Structure 32, 2107\u20132122 (2024).","journal-title":"Structure"},{"key":"1105_CR282","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14697","volume":"8","author":"MY Tang","year":"2017","unstructured":"Tang, M. Y. et al. Structure-guided mutagenesis reveals a hierarchical mechanism of Parkin activation. Nat. Commun. 8, 14697 (2017).","journal-title":"Nat. Commun."},{"key":"1105_CR283","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201419","volume":"6","author":"MU Stevens","year":"2023","unstructured":"Stevens, M. U. et al. Structure-based design and characterization of Parkin-activating mutations. Life Sci. Alliance 6, e202201419 (2023).","journal-title":"Life Sci. Alliance"},{"key":"1105_CR284","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2013.07.016","volume":"93","author":"X Gai","year":"2013","unstructured":"Gai, X. et al. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. Am. J. Hum. Genet. 93, 482\u2013495 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"1105_CR285","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ajhg.2013.07.017","volume":"93","author":"PE Bonnen","year":"2013","unstructured":"Bonnen, P. E. et al. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am. J. Hum. Genet. 93, 471\u2013481 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"1105_CR286","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022113033","volume":"42","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. A mitochondrial SCF-FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease. EMBO J. 42, e113033 (2023).","journal-title":"EMBO J."},{"key":"1105_CR287","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112767","volume":"42","author":"GT Nguyen-Dien","year":"2023","unstructured":"Nguyen-Dien, G. T. et al. FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors. EMBO J. 42, e112767 (2023).","journal-title":"EMBO J."},{"key":"1105_CR288","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41418-023-01205-1","volume":"30","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. FBXL4 mutations cause excessive mitophagy via BNIP3\/BNIP3L accumulation leading to mitochondrial DNA depletion syndrome. Cell Death Differ. 30, 2351\u20132363 (2023).","journal-title":"Cell Death Differ."},{"key":"1105_CR289","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112799","volume":"42","author":"H Elcocks","year":"2023","unstructured":"Elcocks, H. et al. FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels. EMBO J. 42, e112799 (2023).","journal-title":"EMBO J."},{"key":"1105_CR290","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/biom9080296","volume":"9","author":"S Padmanabhan","year":"2019","unstructured":"Padmanabhan, S. et al. The Michael J. Fox foundation for Parkinson\u2019s research strategy to advance therapeutic development of PINK1 and Parkin. Biomolecules 9, 286 (2019).","journal-title":"Biomolecules"},{"key":"1105_CR291","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1080\/15548627.2018.1461294","volume":"14","author":"X Hou","year":"2018","unstructured":"Hou, X. et al. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. Autophagy 14, 1404\u20131418 (2018).","journal-title":"Autophagy"},{"key":"1105_CR292","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00401-024-02699-w","volume":"147","author":"RL Walton","year":"2024","unstructured":"Walton, R. L. et al. Role of GBA variants in Lewy body disease neuropathology. Acta Neuropathol. 147, 54 (2024).","journal-title":"Acta Neuropathol."},{"key":"1105_CR293","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ana.24515","volume":"78","author":"A Pyle","year":"2015","unstructured":"Pyle, A. et al. Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early\u2010stage Parkinson\u2019s disease. Ann. Neurol. 78, 1000\u20131004 (2015).","journal-title":"Ann. Neurol."},{"key":"1105_CR294","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72190-5","volume":"10","author":"H Lowes","year":"2020","unstructured":"Lowes, H. et al. Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease. Sci. Rep. 10, 15253 (2020).","journal-title":"Sci. Rep."},{"key":"1105_CR295","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-020-00362-y","volume":"15","author":"H Lowes","year":"2020","unstructured":"Lowes, H. et al. Circulating cell-free mitochondrial DNA levels in Parkinson\u2019s disease are influenced by treatment. Mol. Neurodegener. 15, 10 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1105_CR296","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23955","volume":"74","author":"P Podlesniy","year":"2013","unstructured":"Podlesniy, P. et al. Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann. Neurol. 74, 655\u2013668 (2013).","journal-title":"Ann. Neurol."},{"key":"1105_CR297","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.3390\/ijms21176298","volume":"21","author":"P Podlesniy","year":"2020","unstructured":"Podlesniy, P. et al. Cerebrospinal fluid mitochondrial DNA in rapid and slow progressive forms of Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 6298 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1105_CR298","doi-asserted-by":"publisher","first-page":"eabo1557","DOI":"10.1126\/scitranslmed.abo1557","volume":"15","author":"R Qi","year":"2023","unstructured":"Qi, R. et al. A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease. Sci. Transl Med. 15, eabo1557 (2023).","journal-title":"Sci. Transl Med."},{"key":"1105_CR299","doi-asserted-by":"publisher","first-page":"105065","DOI":"10.1016\/j.ebiom.2024.105065","volume":"102","author":"M Puigr\u00f2s","year":"2024","unstructured":"Puigr\u00f2s, M. et al. Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder. EBioMedicine 102, 105065 (2024).","journal-title":"EBioMedicine"},{"key":"1105_CR300","doi-asserted-by":"publisher","first-page":"e2683","DOI":"10.1212\/WNL.0000000000201288","volume":"99","author":"J Prasuhn","year":"2022","unstructured":"Prasuhn, J. et al. Assessment of bioenergetic deficits in patients with Parkinson disease and progressive supranuclear palsy using 31P-MRSI. Neurology 99, e2683\u2013e2692 (2022).","journal-title":"Neurology"},{"key":"1105_CR301","doi-asserted-by":"publisher","first-page":"1183228","DOI":"10.3389\/fnagi.2023.1183228","volume":"15","author":"S Jett","year":"2023","unstructured":"Jett, S. et al. Systematic review of 31P-magnetic resonance spectroscopy studies of brain high energy phosphates and membrane phospholipids in aging and Alzheimer\u2019s disease. Front. Aging Neurosci. 15, 1183228 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1105_CR302","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/metabo10010019","volume":"10","author":"G Dossi","year":"2019","unstructured":"Dossi, G., Squarcina, L. & Rango, M. In vivo mitochondrial function in idiopathic and genetic Parkinson\u2019s disease. Metabolites 10, 19 (2019).","journal-title":"Metabolites"},{"key":"1105_CR303","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mds.27946","volume":"35","author":"M Rango","year":"2020","unstructured":"Rango, M. et al. Brain mitochondrial impairment in early\u2010onset Parkinson\u2019s disease with or without PINK1 mutation. Mov. Disord. 35, 504\u2013507 (2020).","journal-title":"Mov. Disord."},{"key":"1105_CR304","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1093\/brain\/awaa340","volume":"143","author":"M Sassani","year":"2020","unstructured":"Sassani, M. et al. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain 143, 3603\u20133618 (2020).","journal-title":"Brain"},{"key":"1105_CR305","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10020-021-00426-9","volume":"28","author":"J Prasuhn","year":"2022","unstructured":"Prasuhn, J. et al. Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson\u2019s disease. Mol. Med. 28, 28 (2022).","journal-title":"Mol. Med."},{"key":"1105_CR306","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/ana.26884","volume":"95","author":"J Prasuhn","year":"2024","unstructured":"Prasuhn, J. et al. Levodopa impairs the energy metabolism of the basal ganglia in vivo. Ann. Neurol. 95, 849\u2013857 (2024).","journal-title":"Ann. Neurol."},{"key":"1105_CR307","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/mds.29450","volume":"38","author":"T Payne","year":"2023","unstructured":"Payne, T. et al. A double\u2010blind, randomized, placebo\u2010controlled trial of ursodeoxycholic acid (UDCA) in Parkinson\u2019s disease. Mov. Disord. 38, 1493\u20131502 (2023).","journal-title":"Mov. Disord."},{"key":"1105_CR308","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","volume":"85","author":"H Mortiboys","year":"2015","unstructured":"Mortiboys, H. et al. UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2G2019S carriers and in vivo. Neurology 85, 846\u2013852 (2015).","journal-title":"Neurology"},{"key":"1105_CR309","doi-asserted-by":"publisher","first-page":"135493","DOI":"10.1016\/j.neulet.2020.135493","volume":"741","author":"H Qi","year":"2021","unstructured":"Qi, H. et al. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP\/MPP+-induced Parkinson\u2019s disease. Neurosci. Lett. 741, 135493 (2021).","journal-title":"Neurosci. Lett."},{"key":"1105_CR310","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-022-00753-3","volume":"19","author":"M Perovnik","year":"2023","unstructured":"Perovnik, M. et al. Functional brain networks in the evaluation of patients with neurodegenerative disorders. Nat. Rev. Neurol. 19, 73\u201390 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1105_CR311","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00415-022-11445-9","volume":"270","author":"A Canosa","year":"2023","unstructured":"Canosa, A. et al. Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study. J. Neurol. 270, 953\u2013959 (2023).","journal-title":"J. Neurol."},{"key":"1105_CR312","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","volume":"83","author":"M Pagani","year":"2014","unstructured":"Pagani, M. et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology 83, 1067\u20131074 (2014).","journal-title":"Neurology"},{"key":"1105_CR313","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1212\/01.wnl.0000338699.56379.11","volume":"72","author":"BFLV Nuenen","year":"2009","unstructured":"Nuenen, B. F. L. V. et al. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology 72, 1041\u20131047 (2009).","journal-title":"Neurology"},{"key":"1105_CR314","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163980","volume":"11","author":"E Makovac","year":"2016","unstructured":"Makovac, E. et al. Brain connectivity changes in autosomal recessive Parkinson disease: a model for the sporadic form. PLoS ONE 11, e0163980 (2016).","journal-title":"PLoS ONE"},{"key":"1105_CR315","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal, B. et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab. 34, 396\u2013407 (2022).","journal-title":"Cell Metab."},{"key":"1105_CR316","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3390\/pharmaceutics14112545","volume":"14","author":"TG Luu","year":"2022","unstructured":"Luu, T. G. & Kim, H.-K. 18F-radiolabeled translocator protein (TSPO) PET tracers: recent development of TSPO radioligands and their application to PET study. Pharmaceutics 14, 2545 (2022).","journal-title":"Pharmaceutics"},{"key":"1105_CR317","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1038\/s41380-021-01050-z","volume":"26","author":"M Frison","year":"2021","unstructured":"Frison, M. et al. The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity. Mol. Psychiatry 26, 2721\u20132739 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1105_CR318","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.biochi.2024.01.012","volume":"224","author":"LH Fairley","year":"2024","unstructured":"Fairley, L. H. et al. Translocator protein (TSPO) ligands attenuate mitophagy deficits in the SH-SY5Y cellular model of Alzheimer\u2019s disease via the autophagy adaptor P62. Biochimie 224, 132\u2013138 (2024).","journal-title":"Biochimie"},{"key":"1105_CR319","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mito.2018.03.001","volume":"46","author":"S Kazami","year":"2019","unstructured":"Kazami, S. et al. BCPP compounds, PET probes for early therapeutic evaluations, specifically bind to mitochondrial complex I. Mitochondrion 46, 97\u2013102 (2019).","journal-title":"Mitochondrion"},{"key":"1105_CR320","doi-asserted-by":"publisher","first-page":"eabk1051","DOI":"10.1126\/scitranslmed.abk1051","volume":"14","author":"AV Venkataraman","year":"2022","unstructured":"Venkataraman, A. V. et al. Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer\u2019s disease. Sci. Transl Med. 14, eabk1051 (2022).","journal-title":"Sci. Transl Med."},{"key":"1105_CR321","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-024-01099-1","volume":"14","author":"E Shatalina","year":"2024","unstructured":"Shatalina, E. et al. Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study. EJNMMI Res. 14, 41 (2024).","journal-title":"EJNMMI Res."},{"key":"1105_CR322","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/brain\/awaa246","volume":"143","author":"M Borsche","year":"2020","unstructured":"Borsche, M. et al. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN\/PINK1 parkinsonism. Brain 143, 3041\u20133051 (2020).","journal-title":"Brain"},{"key":"1105_CR323","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02973-w","volume":"20","author":"K Nordengen","year":"2023","unstructured":"Nordengen, K. et al. Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer\u2019s disease. J. Neuroinflamm. 20, 298 (2023).","journal-title":"J. Neuroinflamm."},{"key":"1105_CR324","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/biomedicines11092394","volume":"11","author":"SMDL Monte","year":"2023","unstructured":"Monte, S. M. D. L., Tong, M. & Hapel, A. J. Concordant and discordant cerebrospinal fluid and plasma cytokine and chemokine responses in mild cognitive impairment and early-stage Alzheimer\u2019s disease. Biomedicines 11, 2394 (2023).","journal-title":"Biomedicines"},{"key":"1105_CR325","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mds.29363","volume":"38","author":"TA Yacoubian","year":"2023","unstructured":"Yacoubian, T. A. et al. Brain and systemic inflammation in de novo Parkinson\u2019s disease. Mov. Disord. 38, 743\u2013754 (2023).","journal-title":"Mov. Disord."},{"key":"1105_CR326","doi-asserted-by":"publisher","first-page":"fcad084","DOI":"10.1093\/braincomms\/fcad084","volume":"5","author":"A-A Roussakis","year":"2023","unstructured":"Roussakis, A.-A. et al. A PET-CT study on neuroinflammation in Huntington\u2019s disease patients participating in a randomized trial with laquinimod. Brain Commun. 5, fcad084 (2023).","journal-title":"Brain Commun."},{"key":"1105_CR327","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","volume":"20","author":"J Therriault","year":"2024","unstructured":"Therriault, J. et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat. Rev. Neurol. 20, 232\u2013244 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1105_CR328","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul, G. et al. \u03b1\u2010synuclein RT\u2010QuIC in the CSF of patients with \u03b1\u2010synucleinopathies. Ann. Clin. Transl. Neurol. 3, 812\u2013818 (2016).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1105_CR329","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"1105_CR330","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41531-024-00738-7","volume":"10","author":"Y Kuang","year":"2024","unstructured":"Kuang, Y. et al. A skin-specific \u03b1-synuclein seeding amplification assay for diagnosing Parkinson\u2019s disease. npj Parkinsons Dis. 10, 129 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1105_CR331","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten, M. et al. Genotype-phenotype relations for the Parkinson\u2019s disease genes parkin, PINK1, DJ1: MDSGene systematic review. Mov. Disord. 33, 730\u2013741 (2018).","journal-title":"Mov. Disord."},{"key":"1105_CR332","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","volume":"19","author":"A Puschmann","year":"2013","unstructured":"Puschmann, A. Monogenic Parkinson\u2019s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat. Disord. 19, 407\u2013415 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1105_CR333","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/brain\/awg142","volume":"126","author":"NL Khan","year":"2003","unstructured":"Khan, N. L. et al. Parkin disease: a phenotypic study of a large case series. Brain 126, 1279\u20131292 (2003).","journal-title":"Brain"},{"key":"1105_CR334","doi-asserted-by":"publisher","first-page":"100.e9","DOI":"10.1016\/j.neurobiolaging.2020.08.014","volume":"99","author":"IJ Swift","year":"2021","unstructured":"Swift, I. J. et al. Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature. Neurobiol. Aging 99, 100.e9\u2013100.e15 (2021).","journal-title":"Neurobiol. Aging"},{"key":"1105_CR335","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/jcm10081623","volume":"10","author":"MV Requardt","year":"2021","unstructured":"Requardt, M. V. et al. Clinical determinants of disease progression in amyotrophic lateral sclerosis-a retrospective cohort study. J. Clin. Med. 10, 1623 (2021).","journal-title":"J. Clin. Med."},{"key":"1105_CR336","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41531-019-0080-x","volume":"5","author":"KJ Billingsley","year":"2019","unstructured":"Billingsley, K. J. et al. Mitochondria function associated genes contribute to Parkinson\u2019s Disease risk and later age at onset. npj Parkinson\u2019s Dis. 5, 8 (2019).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"1105_CR337","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-020-02181-3","volume":"140","author":"S Bandres-Ciga","year":"2020","unstructured":"Bandres-Ciga, S. et al. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Acta Neuropathol. 140, 341\u2013358 (2020).","journal-title":"Acta Neuropathol."},{"key":"1105_CR338","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s42466-019-0033-1","volume":"1","author":"J Prasuhn","year":"2019","unstructured":"Prasuhn, J. et al. An omics-based strategy using coenzyme Q10 in patients with Parkinson\u2019s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial. Neurol. Res. Pract. 1, 31 (2019).","journal-title":"Neurol. Res. Pract."},{"key":"1105_CR339","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-230548","volume":"95","author":"NJ Schork","year":"2023","unstructured":"Schork, N. J., Elman, J. A. & Alzheimer\u2019s Disease Neuroimaging Initiative. Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer\u2019s disease-related biomarkers. J. Alzheimer\u2019s Dis. 95, 915\u2013929 (2023).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1105_CR340","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/brain\/awac327","volume":"146","author":"G Liu","year":"2022","unstructured":"Liu, G. et al. Mitochondrial haplogroups and cognitive progression in Parkinson\u2019s disease. Brain 146, 42\u201349 (2022).","journal-title":"Brain"},{"key":"1105_CR341","doi-asserted-by":"publisher","first-page":"108051","DOI":"10.1016\/j.jbc.2024.108051","volume":"301","author":"JP Wagner","year":"2024","unstructured":"Wagner, J. P., Sauv\u00e9, V., Saran, A. & Gehring, K. Structural basis for the pathogenicity of parkin catalytic domain mutants. J. Biol. Chem. 301, 108051 (2024).","journal-title":"J. Biol. Chem."},{"key":"1105_CR342","doi-asserted-by":"publisher","first-page":"17003","DOI":"10.1073\/pnas.2008030117","volume":"117","author":"HK Bhargava","year":"2020","unstructured":"Bhargava, H. K. et al. Structural basis for autophagy inhibition by the human Rubicon\u2013Rab7 complex. Proc. Natl Acad. Sci. USA 117, 17003\u201317010 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1105_CR343","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202309015","volume":"223","author":"DA Tudorica","year":"2024","unstructured":"Tudorica, D. A. et al. A RAB7A phosphoswitch coordinates Rubicon homology protein regulation of Parkin-dependent mitophagy. J. Cell. Biol. 223, e202309015 (2024).","journal-title":"J. Cell. Biol."},{"key":"1105_CR344","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2023.11.014","volume":"36","author":"T Konig","year":"2024","unstructured":"Konig, T. & McBride, H. M. Mitochondrial-derived vesicles in metabolism, disease, and aging. Cell Metab. 36, 21\u201335 (2024).","journal-title":"Cell Metab."},{"key":"1105_CR345","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.chembiol.2011.05.013","volume":"18","author":"H Katayama","year":"2011","unstructured":"Katayama, H. et al. A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem. Biol. 18, 1042\u20131052 (2011).","journal-title":"Chem. Biol."},{"key":"1105_CR346","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2144\/btn-2020-0071","volume":"69","author":"NJ Winsor","year":"2020","unstructured":"Winsor, N. J. et al. An optimized procedure for quantitative analysis of mitophagy with the mtKeima system using flow cytometry. Biotechniques 69, 249\u2013256 (2020).","journal-title":"Biotechniques"},{"key":"1105_CR347","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/cells8070712","volume":"8","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Mitophagy in Parkinson\u2019s disease: from pathogenesis to treatment. Cells 8, 712 (2019).","journal-title":"Cells"},{"key":"1105_CR348","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cell.2020.04.025","volume":"181","author":"H Katayama","year":"2020","unstructured":"Katayama, H. et al. Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration. Cell 181, 1176\u20131187 (2020).","journal-title":"Cell"},{"key":"1105_CR349","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003722","volume":"9","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J. et al. Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog. 9, e1003722 (2013).","journal-title":"PLoS Pathog."},{"key":"1105_CR350","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4161\/auto.5331","volume":"4","author":"CJ Rosado","year":"2008","unstructured":"Rosado, C. J. et al. Rosella: a fluorescent pH-biosensor for reporting vacuolar turnover of cytosol and organelles in yeast. Autophagy 4, 205\u2013213 (2008).","journal-title":"Autophagy"},{"key":"1105_CR351","doi-asserted-by":"publisher","DOI":"10.1038\/srep12397","volume":"5","author":"A Sargsyan","year":"2015","unstructured":"Sargsyan, A. et al. Rapid parallel measurements of macroautophagy and mitophagy in mammalian cells using a single fluorescent biosensor. Sci. Rep. 5, 12397 (2015).","journal-title":"Sci. Rep."},{"key":"1105_CR352","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mito.2017.12.008","volume":"44","author":"RJ Wilson","year":"2019","unstructured":"Wilson, R. J. et al. Conditional MitoTimer reporter mice for assessment of mitochondrial structure, oxidative stress, and mitophagy. Mitochondrion 44, 20\u201326 (2019).","journal-title":"Mitochondrion"},{"key":"1105_CR353","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4161\/auto.26501","volume":"9","author":"G Hernandez","year":"2013","unstructured":"Hernandez, G. et al. MitoTimer: a novel tool for monitoring mitochondrial turnover. Autophagy 9, 1852\u20131861 (2013).","journal-title":"Autophagy"},{"key":"1105_CR354","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.1002\/jcp.30404","volume":"236","author":"SI Yamashita","year":"2021","unstructured":"Yamashita, S. I. et al. Mitophagy reporter mouse analysis reveals increased mitophagy activity in disuse-induced muscle atrophy. J. Cell Physiol. 236, 7612\u20137624 (2021).","journal-title":"J. Cell Physiol."},{"key":"1105_CR355","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78923","volume":"11","author":"WW Yim","year":"2022","unstructured":"Yim, W. W., Yamamoto, H. & Mizushima, N. A pulse-chasable reporter processing assay for mammalian autophagic flux with HaloTag. eLife 11, e78923 (2022).","journal-title":"eLife"},{"key":"1105_CR356","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1038\/s44318-024-00272-5","volume":"43","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Autophagy adaptors mediate Parkin-dependent mitophagy by forming sheet-like liquid condensates. Embo J. 43, 5613\u20135634 (2024).","journal-title":"Embo J."},{"key":"1105_CR357","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","volume":"1","author":"PA Andreux","year":"2019","unstructured":"Andreux, P. A. et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat. Metab. 1, 595\u2013603 (2019).","journal-title":"Nat. Metab."},{"key":"1105_CR358","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","volume":"27","author":"D D\u2019Amico","year":"2021","unstructured":"D\u2019Amico, D. et al. Impact of the natural compound urolithin A on health, disease, and aging. Trends Mol. Med. 27, 687\u2013699 (2021).","journal-title":"Trends Mol. Med."},{"key":"1105_CR359","first-page":"7340","volume":"20","author":"WJ Jagust","year":"2024","unstructured":"Jagust, W. J. et al. The ADNI PET Core at 20. Alzheimers Dement. 20, 7340\u20137349 (2024).","journal-title":"Alzheimers Dement"},{"key":"1105_CR360","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/brain\/awac394","volume":"146","author":"M Benatar","year":"2023","unstructured":"Benatar, M., Wuu, J. & Turner, M. R. Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal. Brain 146, 2711\u20132716 (2023).","journal-title":"Brain"},{"key":"1105_CR361","unstructured":"FDA grants accelerated approval for Alzheimer\u2019s drug. FDA https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-alzheimers-drug (2021)."},{"key":"1105_CR362","unstructured":"FDA grants accelerated approval for Alzheimer\u2019s disease treatment. FDA https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-alzheimers-disease-treatment (2023)."},{"key":"1105_CR363","unstructured":"FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene. FDA https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene (2023)."},{"key":"1105_CR364","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.neuron.2024.05.006","volume":"112","author":"H Endo","year":"2024","unstructured":"Endo, H. et al. Imaging \u03b1-synuclein pathologies in animal models and patients with Parkinson\u2019s and related diseases. Neuron 112, 2540\u20132557 (2024).","journal-title":"Neuron"}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41573-024-01105-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-024-01105-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-024-01105-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:33:39Z","timestamp":1743788019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41573-024-01105-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":364,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1038\/s41573-024-01105-0","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"25 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.A. declares no completing interests. M.M.K.M. is a member of the Scientific Advisory Board of Montara Therapeutics Inc. and scientific consultant to Merck, Sharp and Dohme. P.W.T. is a Mission Therapeutics share option holder. N.T.H. was co-founder and Chief Scientific Officer at Mitokinin, a company that developed PINK1 activators. L.E.P. is a Mission Therapeutics share option holder.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}